| Liver tumour immune microenvironment subtypes and neutrophil heterogeneity R Xue, Q Zhang, Q Cao, R Kong, X Xiang, H Liu, M Feng, F Wang, ... Nature 612 (7938), 141-147, 2022 | 393 | 2022 |
| Therapy of primary liver cancer M Feng, Y Pan, R Kong, S Shu The Innovation 1 (2), 2020 | 92 | 2020 |
| The administration of Escherichia coli Nissle 1917 ameliorates irinotecan–induced intestinal barrier dysfunction and gut microbial dysbiosis in mice Y Wang, L Sun, S Chen, S Guo, T Yue, Q Hou, M Feng, H Xu, Y Liu, ... Life sciences 231, 116529, 2019 | 53 | 2019 |
| Rictor promotes cell migration and actin polymerization through regulating ABLIM1 phosphorylation in Hepatocellular Carcinoma X Dong, M Feng, H Yang, H Liu, H Guo, X Gao, Y Liu, R Liu, N Zhang, ... International journal of biological sciences 16 (15), 2835, 2020 | 21 | 2020 |
| Upregulated MMP28 in hepatocellular carcinoma promotes metastasis via Notch3 signaling and predicts unfavorable prognosis J Zhou, X Zheng, M Feng, Z Mo, Y Shan, Y Wang, J Jin International journal of biological sciences 15 (4), 812, 2019 | 20 | 2019 |
| Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer M Feng, F Wang, X Liu, T Hao, N Zhang, M Deng, Y Pan, R Kong Cancer Biology & Medicine 20 (6), 421, 2023 | 12 | 2023 |
| The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma M Feng, H Xu, W Zhou, Y Pan Journal of Experimental & Clinical Cancer Research 42 (1), 44, 2023 | 10 | 2023 |
| The protective effect of Escherichia coli Nissle 1917 on the intestinal barrier is mediated by inhibition of RhoA/ROCK2/MLC signaling via TLR-4 H Xu, Q Hou, J Zhu, M Feng, P Wang, Y Pan Life Sciences 292, 120330, 2022 | 8 | 2022 |
| Integrative molecular and spatial analysis reveals evolutionary dynamics and tumor-immune interplay of in situ and invasive acral melanoma H Liu, J Gao, M Feng, J Cheng, Y Tang, Q Cao, Z Zhao, Z Meng, J Zhang, ... Cancer Cell 42 (6), 1067-1085. e11, 2024 | 7 | 2024 |
| The breakthrough in primary human hepatocytes in vitro expansion M Feng, R Kong, Y Pan Cancer Biology & Medicine 16 (1), 1, 2019 | 6 | 2019 |
| YAP inhibition overcomes adaptive resistance in HER2-positive gastric cancer treated with trastuzumab via the AKT/mTOR and ERK/mTOR axis J Qiao, M Feng, W Zhou, Y Tan, S Yang, Q Liu, Q Wang, W Feng, Y Pan, ... Gastric Cancer, 1-17, 2024 | 1 | 2024 |
| A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma W Zhou, M Feng, F Qi, J Qiao, L Fan, L Zhang, X Hu, C Huang European Archives of Oto-Rhino-Laryngology 281 (2), 953-963, 2024 | | 2024 |
